LCGC North America Editorial Advisory Board
The Publishers of LC•GC North America would like to thank the members of the Editorial Advisory Board for their continuing support and expert advice. The high standards and editorial quality associated with LC•GC North America are maintained largely through the tireless efforts of these individuals.
Kevin D. Altria GlaxoSmithKline, Ware, United Kingdom
Jared L. Anderson The University of Toledo, Toledo, Ohio
Daniel W. Armstrong University of Texas, Arlington, Texas
Michael P. Balogh Waters Corp., Milford, Massachusetts
Brian A. Bidlingmeyer Agilent Technologies, Wilmington, Delaware
Dennis D. Blevins Agilent Technologies, Wilmington, Delaware
Peter Carr Department of Chemistry, University of Minnesota, Minneapolis, Minnesota
Jean-Pierre Chervet Antec Leyden, Zoeterwoude, The Netherlands
John W. Dolan LC Resources, Walnut Creek, California
Michael W. Dong Genentech, San Francisco, California
Roy Eksteen Sigma-Aldrich/Supelco, Bellefonte, Pennsylvania
Anthony F. Fell School of Pharmacy, University of Bradford, Bradford, United Kingdom
Francesco Gasparrini Dipartimento di Studi di Chimica e Tecnologia delle Sostanze Biologicamente Attive, Università “La Sapienza,” Rome, Italy
Joseph L. Glajch Momenta Pharmaceuticals, Cambridge, Massachusetts
Davy Guillarme University of Geneva, University of Lausanne, Geneva, Switzerland
Richard Hartwick PharmAssist Analytical Laboratory, Inc., South New Berlin, New York
Milton T.W. Hearn Center for Bioprocess Technology, Monash University, Clayton, Victoria, Australia
Emily Hilder University of Tasmania, Hobart, Tasmania, Australia John V. Hinshaw BPL Global, Ltd., Hillsboro, Oregon
Kiyokatsu Jinno School of Materials Science, Toyohashi University of Technology, Toyohashi, Japan
Ira S. Krull Northeastern University, Boston, Massachusetts
Ronald E. Majors LCGC columnist and analytical consultant, West Chester, Pennsylvania
R.D. McDowall McDowall Consulting, Bromley, United Kingdom
Michael D. McGinley Phenomenex, Inc., Torrance, California Victoria A. McGuffin Department of Chemistry, Michigan State University,
East Lansing, Michigan
Mary Ellen McNally E.I. du Pont de Nemours & Co., Wilmington, Delaware
Imre Molnár Molnar Research Institute, Berlin, Germany
Glenn I. Ouchi Brego Research, San Jose, California
Colin Poole Department of Chemistry, Wayne State University, Detroit, Michigan
Fred E. Regnier Department of Chemistry, Purdue University, West Lafayette, Indiana
Pat Sandra Research Institute for Chromatography, Kortrijk, Belgium
Peter Schoenmakers Department of Chemical Engineering, University of Amsterdam, Amsterdam, The Netherlands
Kevin Schug University of Texas, Arlington, Texas
Dwight Stoll Gustavus Adolphus College, St. Peter, Minnesota
Michael E. Swartz Ariad Pharmaceuticals, Cambridge, Massachusetts
Thomas Wheat Waters Corporation, Milford, Massachusetts
Consulting Editors: Jason Anspach, Phenomenex, Inc.; David Henderson, Trinity College; Tom Jupille, LC Resources; Sam Margolis, The National Institute of Standards and Technology; Joy R. Miksic, Bioanalytical Solutions LLC.
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.